Cargando…

Oncogenic MYC amplifies mitotic perturbations

The oncogenic transcription factor MYC modulates vast arrays of genes, thereby influencing numerous biological pathways including biogenesis, metabolism, proliferation, apoptosis and pluripotency. When deregulated, MYC drives genomic instability via several mechanisms including aberrant proliferatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Littler, Samantha, Sloss, Olivia, Geary, Bethany, Pierce, Andrew, Whetton, Anthony D., Taylor, Stephen S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731591/ https://www.ncbi.nlm.nih.gov/pubmed/31455158 http://dx.doi.org/10.1098/rsob.190136

Ejemplares similares

MYC Is a Major Determinant of Mitotic Cell Fate
por: Topham, Caroline, et al.
Publicado: (2015)

Inhibition of Bcl-xL sensitizes cells to mitotic blockers, but not mitotic drivers
por: Bennett, Ailsa, et al.
Publicado: (2016)

Mcl-1 dynamics influence mitotic slippage and death in mitosis
por: Sloss, Olivia, et al.
Publicado: (2016)

AMPLIFIED ALLELE OF THE HUMAN N‐myc ONCOGENE IN NEUROBLASTOMAS
por: Yamada, Masao, et al.
Publicado: (1988)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

MEDB-81. Combined inhibition of CDK11 and EZH2 results in regression of MYC-amplified medulloblastoma
por: Wang, Dong, et al.
Publicado: (2022)

Comprehensive Library Generation for Identification and Quantification of Endometrial Cancer Protein Biomarkers in Cervico-Vaginal Fluid
por: Njoku, Kelechi, et al.
Publicado: (2021)

Oncogenic KRAS triggers MAPK-dependent errors in mitosis and MYC-dependent sensitivity to anti-mitotic agents
por: Perera, David, et al.
Publicado: (2016)

A brave new MYC-amplified world
por: Weinberg, Marc S., et al.
Publicado: (2015)

Identification of curaxin as a potential new therapeutic for JAK2 V617F mutant patients
por: Pearson, Stella, et al.
Publicado: (2023)

Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells
por: Pearson, Stella, et al.
Publicado: (2022)

OptiMissP: A dashboard to assess missingness in proteomic data-independent acquisition mass spectrometry
por: Arioli, Angelica, et al.
Publicado: (2021)

Myc, Oncogenic Protein Translation, and the Role of Polyamines
por: Flynn, Andrea T., et al.
Publicado: (2018)

Myc stimulates B lymphocyte differentiation and amplifies calcium signaling
por: Habib, Tania, et al.
Publicado: (2007)

A Regulatory Loop of FBXW7-MYC-PLK1 Controls Tumorigenesis of MYC-Driven Medulloblastoma
por: Wang, Dong, et al.
Publicado: (2021)

Profiling DNA damage response following mitotic perturbations
por: S. Pedersen, Ronni, et al.
Publicado: (2016)

Coamplification of the L‐myc and N‐myc Oncogenes in a Neuroblastoma Cell Line
por: Jinbo, Takeshi, et al.
Publicado: (1989)

Over-expression of the c-myc proto-oncogene in colorectal carcinoma.
por: Smith, D. R., et al.
Publicado: (1993)

MEDB-39. Oncogenic mechanisms underlying GLI2-amplified medulloblastoma
por: Murad, Najiba, et al.
Publicado: (2022)

Omomyc Reveals New Mechanisms To Inhibit the MYC Oncogene
por: Demma, Mark J., et al.
Publicado: (2019)

Oncogene addiction to c-MYC in myeloma cells
por: Holien, Toril, et al.
Publicado: (2012)

Detection of the c-myc oncogene product in testicular cancer.
por: Sikora, K., et al.
Publicado: (1985)

Spindle pole bodies function as signal amplifiers in the Mitotic Exit Network
por: Campbell, Ian W., et al.
Publicado: (2020)

Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumour heterogeneity
por: Fonseka, Pamali, et al.
Publicado: (2019)

Metabolomic Biomarkers for the Detection of Obesity-Driven Endometrial Cancer
por: Njoku, Kelechi, et al.
Publicado: (2021)

Tumor Treating Fields Perturb the Localization of Septins and Cause Aberrant Mitotic Exit
por: Gera, Nidhi, et al.
Publicado: (2015)

High Intrinsic Oncogenic Potential in the Myc-Box-Deficient Hydra Myc3 Protein
por: Lechable, Marion, et al.
Publicado: (2023)

Crystal structure of the major quadruplex formed in the promoter region of the human c-MYC oncogene
por: Stump, Sascha, et al.
Publicado: (2018)

THOC5 complexes with DDX5, DDX17, and CDK12 to regulate R loop structures and transcription elongation rate
por: Polenkowski, Mareike, et al.
Publicado: (2022)

Clinical Importance of Myc Family Oncogene Aberrations in Epithelial Ovarian Cancer
por: Jung, MoonSun, et al.
Publicado: (2018)

Mistletoe lectin inhibits growth of Myc‐amplified small‐cell lung cancer
por: Shatat, Mohammad A., et al.
Publicado: (2022)

Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma: Results of the Proof-of-Concept iMYC Study
por: Turkes, Fiona, et al.
Publicado: (2022)

Oncogenes induce genotoxic stress by mitotic processing of unusual replication intermediates
por: Neelsen, Kai J., et al.
Publicado: (2013)

Detection of the c-myc oncogene product in colonic polyps and carcinomas.
por: Stewart, J., et al.
Publicado: (1986)

MYC Oncogene Contributions to Release of Cell Cycle Brakes
por: García-Gutiérrez, Lucía, et al.
Publicado: (2019)

Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency
por: Barna, Maria, et al.
Publicado: (2008)

Targeting oncogenic Myc as a strategy for cancer treatment
por: Chen, Hui, et al.
Publicado: (2018)

MEDB-36. Clinical and molecular heterogeneity withinMYC andMYCN amplified medulloblastoma
por: Schwalbe, Edward, et al.
Publicado: (2022)

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination
por: Wu, Xiaofang, et al.
Publicado: (2021)

MEDB-79. MYC-driven upregulation of thede novo serine and glycine pathway is a novel therapeutic target for Group 3 MYC-amplified Medulloblastoma
por: Adiamah, Magretta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ni9jg4vgfto1k55l05up75igd1